A prospective study to evaluate efficacy using the nuro ™ percutaneous tibial neuromodulation system in drug-naÏve patients with overactive bladder syndrome (oab)

To evaluate changes from baseline in urgency urinary incontinence (UUI) episodes, urinary frequency (UF) and quality of life through 12 weeks of percutaneous tibial neuromodulation (PTNM) therapy using NURO in drug-na ïve OAB subjects.

Source: Urology - June 10, 2019 Category: Urology & Nephrology Authors: Kathleen Kobashi, Victor Nitti, Eric Margolis, Peter Sand, Steven Siegel, Salil Khandwala, Diane Newman, Scott A. MacDiarmid, Fangyu Kan, Elizabeth Michaud Source Type: research